-+ 0.00%
-+ 0.00%
-+ 0.00%

REIN THERAPEUTICS RECEIVES ORPHAN DRUG DESIGNATION FROM EUROPEAN MEDICINES AGENCY FOR LEAD DRUG CANDIDATE IN IDIOPATHIC PULMONARY FIBROSIS

Reuters·01/20/2026 13:00:06

Please log in to view news